Dott.Giovanni Fellegara

 

Nome: Giovanni Fellegara

Specialistica: Anatomia Patologica

Sedi: CDI Saint Bon

Contatta

 

TITOLI ACCADEMICI

  • 2002: Laurea in Medicina e Chirurgia presso l’Università degli Studi di Parma.
  • 2007: Specializzazione in Anatomia Patologica presso l’Università degli Studi di Parma
  • 2011: Dottorato di ricerca in Fisiopatologia Sistemica presso l’Università degli Studi di Parma

ESPERIENZE PROFESSIONALI

  • 2003-2008: Medico prestante servizio di continuità assistenziale presso l’ AUSL di Piacenza, Distretto Val d’Arda
  • 2008-2015: Medico consulente in Anatomia Patologica Centro Diagnostico Italiano
  • dal 2015: Responsabile Anatomia Patologica Centro Diagnostico Italiano

PRINCIPALI SETTORI ATTIVITÀ AL CDI

  • Anatomia Patologica

 

ATTIVITA' SCIENTIFICA E ULTIME PUBBLICAZIONI

  • Ha collaborato alla stesura della “WHO Classification of Tumours of Endocrine Organs, 4th edition” nei capitoli “Poorly differentiated Thyroid Carcinoma” e “Anaplastic Thyroid Carcinoma”
  • Jaconi M, Manzoni M, Pincelli AI, Giardini V, Scardilli M, Smith A, Fellegara G, Pagni F. The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours. Cytopathology. 2017 Dec;28(6):495-502. doi: 10.1111/cyt.12459. Epub 2017 Sep 3. PubMed PMID: 28868665.
  • Du E, Wenig BM, Su HK, Rowe ME, Haser GC, Asa SL, Baloch Z, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML. Inter Observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma. Thyroid. 2016 Jun;26(6):816-9. doi: 10.1089/thy.2015.0551. PubMed PMID: 27089928.
  • Su HK, Wenig BM, Haser GC, Rowe ME, Asa SL, Baloch Z, Du E, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML. Inter Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma. Thyroid. 2016 Apr;26(4):512-7. doi: 10.1089/thy.2015.0508. PubMed PMID: 26953223; PubMed Central PMCID: PMC5583558.
  • Dorji T, Monti V, Fellegara G, Gabba S, Grazioli V, Repetti E, Marcialis C, Peluso S, Di Ruzza D, Neri F, Foschini MP.Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions. Hum Pathol. 2015 Sep;46(9):1275-81.
  • Fellegara G, Rosai J. Gross appearance of multifocal fibrosing thyroiditis. Am J Surg Pathol. 2015 Jun;39(6):870.
    6. Campobasso D, Thai E, Barbieri A, Ziglioli F, Maestroni U, Fellegara G, Ricci R. Recurrent apocrine carcinoma of the scrotum: a case report. Pathol Res Pract. 2015 Mar;211(3):264-7
  • Fellegara G, Rosai J. Multifocal Fibrosing Thyroiditis: Report of 55 Cases of a Poorly Recognized Entity. Am J Surg Pathol. 2015 Mar;39(3):416-24
  • Fellegara G, Basciu M, Pagni F, Oriana S. Phytoestrogens and breast carcinoma: a word of caution. Eur J Cancer Prev. 2014 Sep;23(5):491-2. doi: 10.1097/CEJ.0000000000000022. PubMed PMID: 25068807.
  • Fellegara G, Gabba S, Dorji T, De Luca G, Colecchia M. Observations on Aron et al's "Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3 CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia". Am J Surg Pathol. 2014 Jul;38(7):1013-5. doi: 10.1097/PAS.0000000000000191. PubMed PMID: 24618606.
  • Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G. Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer. 2013 Dec 16;21(1):1-16. doi: 10.1530/ERC-13-0246. Print 2014 Feb. PubMed PMID: 24344249.
  • Cibas ES, Baloch ZW, Fellegara G, LiVolsi VA, Raab SS, Rosai J, Diggans J, Friedman L, Kennedy GC, Kloos RT, Lanman RB, Mandel SJ, Sindy N, Steward DL, Zeiger MA, Haugen BR, Alexander EK. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013 Sep 3;159(5):325-32. doi: 10.7326/0003-4819-159-5-201309030-00006. PubMed PMID: 24026318.
  • Fellegara G, Rosai J. Multifocal capillary hemangioma-like vascular proliferation of the kidney associated with clear cell renal cell carcinoma: a case report and review of the literature. Int J Surg Pathol. 2013 Aug;21(4):424 6. doi: 10.1177/1066896912474340. Epub 2013 Jan 30. Review. PubMed PMID: 23364358.
  • Giordano G, Fellegara G, Brigati F, Gramellini D, Magnani C. Value of autopsy in renal malformations: comparison of clinical diagnosis and post-mortem examination. Acta Biomed. 2011 Dec;82(3):230-43. PubMed PMID: 22783720.
  • Ramirez Y, Fellegara G, Bugiani M. Eccrine porocarcinoma with carcinomatous lymphangitis in a patient with history of arsenic exposure: a case report. Int J Surg Pathol. 2012 Oct;20(5):515-8. Epub 2011 Nov 21. PubMed PMID: 22108500.
  • Fellegara G, Carcangiu ML, Rosai J. Benign epithelial inclusions in axillary lymph nodes: report of 18 cases and review of the literature. Am J Surg Pathol. 2011 Aug;35(8):1123-33. doi: 10.1097/PAS.0b013e3182237985. Review. PubMed PMID: 21753696